Homo sapiens
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA102975 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:Tanshinones are the major bioactive compounds of Salvia miltiorrhiza Bunge (Danshen), roots, which are used in many therapeutic remedies in Chinese traditional medicine. We investigated the anticancer effects of tanshinones on the highly invasive human lung adenocarcinoma cell line, CL1-5. Tanshinone I significantly inhibited migration, invasion, and gelatinase activity in macrophage-conditioned medium (CM)-stimulated CL1-5 cells in vitro and also reduced the tumorigenesis and metastasis in CL1-5-bearing severe combined immunodeficiency mice. Unlike tanshinone IIA, which induces cell apoptosis, tanshinone I had no significant cytotoxicity. Real-time quantitative polymerase chain reaction (RTQ-PCR), luciferase reporter assay, and an electrophoretic mobility shift assay revealed that tanshinone I reduces the transcriptional activity of interleukin-8 (IL-8), the angiogenic factor involved in cancer metastasis, by attenuating the DNA-binding activity of activator protein-1 and nuclear factor kappaB in CM-stimulated CL1-5 cells. Microarray and pathway analysis of tumor-related genes identified the differentially expressed genes responding to tanshinone I, and these results were validated by RTQ-PCR. The responsive genes included human platelet-derived growth factor beta chain, Shb, H-ras, N-Ras, mitogen-activated protein kinase kinase 3, phosphoinositide-3-kinase, CD44, Rac1, and collagen type IV; these genes may be associated with the Ras MAPK and Rac1 signaling pathways. These results suggest that tanshinone I exhibits anticancer effects both in vitro and in vivo, and that these effects are mediated at least partly through the IL-8, Ras MAPK, and Rac1 signaling pathways. Keywords: treatment with dose respone, cDNA array
2008-12-31 | GSE9315 | GEO
Project description:PNAs-A15 effects on non-small cell lung cancer cell line
| PRJNA315439 | ENA
Project description:Human Non-Small Cell Lung Cancer cells: Control vs gefitinib treated cells
| PRJNA406984 | ENA
Project description:MYEOV as a novel biomarker for human non-small cell lung cancer
| PRJNA275608 | ENA
Project description:Expression data from Non small cell lung cancer cell lines
| PRJNA111915 | ENA
Project description:Measuring competitive exclusion in non-small cell lung cancer
| PRJNA801780 | ENA
Project description:Gene expression in hypoxic non-small cell lung cancer
| PRJNA146187 | ENA
Project description:Expression Data from human Lung tissue of Patients with Non Small Cell Lung Cancer (NSCLC)
| PRJNA145487 | ENA